Finance

Lists
ENTX:NASDAQ
Entera Bio Ltd
US$ ३.०२
-०.९८%
(-०.०३०) 1D
US$ २.९३
-२.८२% (-०.०८५)
Pre-market
Closed: अक्टोबर २२, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
US$ ३.०१
High
US$ ३.०४
Low
US$ २.९०
Mkt. cap
५२.५२ करोड
Avg. vol.
६.०० लाख
Volume
५००.००
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३५
Beta
१.४०
Shares outstanding
१७.३९ करोड
No. of employees
२१
Open
US$ ३.०१
High
US$ ३.०४
Low
US$ २.९०
Mkt. cap
५२.५२ करोड
Avg. vol.
६.०० लाख
Volume
५००.००
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३५
Beta
१.४०
Shares outstanding
१७.३९ करोड
No. of employees
२१
News stories
From web sources and news partners
The Chronicle-Journal
The Chronicle-Journal
·
२३ मिनेट पहिले
SLB’s (NYSE:SLB) Q3 2026: beats on revenue
FinancialContent
FinancialContent
·
४४ मिनेट पहिले
Flagstar Financial (NYSE:FLG) misses Q3 2026 revenue estimates
Yahoo Finance
Yahoo Finance
·
२४ मिनेट पहिले
Invesco NASDAQ 100 ETF (QQQM) Adds NVIDIA and Apple on Wednesday
About Entera Bio Ltd
CEO-
Employees२१
Founded२००९
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current US$ ३.०२
US$ ११.०० (+२६४.२४%)
Average
US$ १०.०० (+२३१.१३%)
Lowest
US$ ९.०० (+१९८.०१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Initiated
US$ ११.००
+२६४.२%
09/24/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
US$ १०.००
+२३१.१%
09/23/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
US$ ९.००
+१९८%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ९.००
+१९८%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१६.४३ लाख
१७.१८ लाख
२२.५१ लाख
३२.०१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१६.१३ लाख
१३.२४ लाख
१२.८८ लाख
१३.६२ लाख
Operating expense
३२.५६ लाख
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
Total operating expenses
३२.५६ लाख
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
Operating income
-३२.५६ लाख
-३०.४२ लाख
-३५.३९ लाख
-४५.६३ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
EBT excluding unusual items
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
५६.०० हजार
२६.०० हजार
३४.०० हजार
-
Interest expense
-
-
-
-२७.४९ लाख
Net interest expenses
५६.०० हजार
२६.०० हजार
३४.०० हजार
-२७.४९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३२.४८ लाख
-३०.३५ लाख
-३५.३२ लाख
-४५.५४ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू